1. Apixaban

   Case report 03 October 2020 Pages: 51 - 51

2. Apixaban/heparin

   Case report 03 October 2020 Pages: 52 - 52

3. Apremilast

   Case report 03 October 2020 Pages: 53 - 53

4. Aspirin/dabigatran-etexilate

   Case report 03 October 2020 Pages: 54 - 54

5. Atomoxetine

   Case report 03 October 2020 Pages: 55 - 55

6. Atropine/dobutamine

   Case report 03 October 2020 Pages: 56 - 56

7. Axitinib/nivolumab

   Case report 03 October 2020 Pages: 57 - 57

8. Azacitidine

   Case report 03 October 2020 Pages: 58 - 58

9. Azacitidine/cytarabine/erythropoietin

   Case report 03 October 2020 Pages: 59 - 59

10. Azathioprine

    Case report 03 October 2020 Pages: 60 - 60

11. Azathioprine/bortezomib

    Case report 03 October 2020 Pages: 61 - 61

12. Azathioprine/ciclosporin/prednisone

    Case report 03 October 2020 Pages: 62 - 62

13. Azathioprine/ganciclovir/methylprednisolone

    Case report 03 October 2020 Pages: 63 - 63

14. Azithromycin

    Case report 03 October 2020 Pages: 64 - 64

15. Azithromycin/hydroxychloroquine

    Case report 03 October 2020 Pages: 65 - 65

16. Bedaquiline/delamanid

    Case report 03 October 2020 Pages: 66 - 66

17. Bendamustine/brentuximab vedotin

    Case report 03 October 2020 Pages: 67 - 67

18. Bevacizumab

    Case report 03 October 2020 Pages: 68 - 68

19. Bisoprolol/dextran sulfate

    Case report 03 October 2020 Pages: 69 - 69

20. Bleomycin

    Case report 03 October 2020 Pages: 70 - 70

21. Blinatumomab

    Case report 03 October 2020 Pages: 71 - 71

22. Bortezomib/dexamethasone/venetoclax

    Case report 03 October 2020 Pages: 72 - 72

23. Bortezomib/immunosuppressants

    Case report 03 October 2020 Pages: 73 - 73

24. Botulinum toxin/general anaesthetics

    Case report 03 October 2020 Pages: 74 - 74

25. Brivaracetam/lacosamide/valproic-acid

    Case report 03 October 2020 Pages: 75 - 75

26. Budesonide

    Case report 03 October 2020 Pages: 76 - 76

27. Busulfan/cyclophosphamide/melphalan

    Case report 03 October 2020 Pages: 77 - 77

28. Capecitabine/cisplatin

    Case report 03 October 2020 Pages: 78 - 78

29. Capecitabine/temozolomide

    Case report 03 October 2020 Pages: 79 - 79

30. Cefalexin/furosemide

    Case report 03 October 2020 Pages: 80 - 80

31. Cefixime

    Case report 03 October 2020 Pages: 81 - 81

32. Cefuroxime

    Case report 03 October 2020 Pages: 82 - 82

33. Celecoxib/rivaroxaban

    Case report 03 October 2020 Pages: 83 - 83

34. Certolizumab pegol

    Case report 03 October 2020 Pages: 84 - 84

35. Cetrorelix/follitropin-α/lutropin-α

    Case report 03 October 2020 Pages: 85 - 85

36. Cetuximab

    Case report 03 October 2020 Pages: 86 - 86

37. Cetuximab/fluorouracil

    Case report 03 October 2020 Pages: 87 - 87

38. Chemotherapy/pegaspargase/prednisolone

    Case report 03 October 2020 Pages: 88 - 88

39. Ciclosporin/mycophenolic acid/prednisolone

    Case report 03 October 2020 Pages: 89 - 89

40. Ciprofloxacin

    Case report 03 October 2020 Pages: 90 - 90

41. Ciprofloxacin

    Case report 03 October 2020 Pages: 91 - 91

42. Cisplatin

    Case report 03 October 2020 Pages: 92 - 92

43. Cisplatin/melphalan

    Case report 03 October 2020 Pages: 93 - 93

44. Cisplatin/pemetrexed

    Case report 03 October 2020 Pages: 94 - 94

45. Clindamycin/doxycycline

    Case report 03 October 2020 Pages: 95 - 95

46. Clindamycin/piperacillin/tazobactam

    Case report 03 October 2020 Pages: 96 - 96

47. Clopidogrel

    Case report 03 October 2020 Pages: 97 - 97

48. Clotrimazole

    Case report 03 October 2020 Pages: 98 - 98

49. Clozapine/hib-meningococcal-vaccine-group-C-conjugate/pneumococcal-vaccine

    Case report 03 October 2020 Pages: 99 - 100

50. Cobimetinib/vemurafenib

    Case report 03 October 2020 Pages: 100 - 100